Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014

NCT01026402 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignancies

Interventions

DRUG: AZD2014

Sponsor

AstraZeneca